209 related articles for article (PubMed ID: 27189275)
41. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.
Hou X; Wu X; Huang P; Zhan J; Zhou T; Ma Y; Qin T; Luo R; Feng Y; Xu Y; Chen L; Zhang L
Int J Cancer; 2015 Oct; 137(7):1672-8. PubMed ID: 25824984
[TBL] [Abstract][Full Text] [Related]
42. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
43. [Multivariate analysis of prognostic makers in patients with nasopharyngeal carcinoma intreatment of radiotherapy combined with induction chemotherapy].
Liu J; Li S; Wang Y; Shi Y; Zhu L; Wu C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):937-40. PubMed ID: 26596014
[TBL] [Abstract][Full Text] [Related]
44. Pregnancy associated nasopharyngeal carcinoma: A retrospective case-control analysis of maternal survival outcomes.
Cheng YK; Zhang F; Tang LL; Chen L; Zhou GQ; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Guo Y; Ma J
Radiother Oncol; 2015 Jul; 116(1):125-30. PubMed ID: 26104977
[TBL] [Abstract][Full Text] [Related]
45. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.
Thephamongkhol K; Setakornnukul J; Rojwatkarnjana S; Chansilpa Y
Int J Biol Markers; 2014 Dec; 29(4):e387-94. PubMed ID: 25198554
[TBL] [Abstract][Full Text] [Related]
46. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
[TBL] [Abstract][Full Text] [Related]
47. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer.
Lin S; Tham IW; Pan J; Han L; Chen Q; Lu JJ
Am J Clin Oncol; 2012 Oct; 35(5):474-9. PubMed ID: 21577086
[TBL] [Abstract][Full Text] [Related]
48. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors.
Vlantis AC; Chan HS; Tong MC; Yu BK; Kam MK; van Hasselt CA
Head Neck; 2011 Aug; 33(8):1126-31. PubMed ID: 21755557
[TBL] [Abstract][Full Text] [Related]
49. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors and outcome for nasopharyngeal carcinoma.
Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
[TBL] [Abstract][Full Text] [Related]
51. Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.
Chen M; Tang LL; Sun Y; Mao YP; Li WF; Guo R; Liu LZ; Li L; Lin AH; Ma J
Head Neck; 2014 Apr; 36(4):468-73. PubMed ID: 23780916
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in metastatic nasopharyngeal carcinoma.
Khanfir A; Frikha M; Ghorbel A; Drira MM; Daoud J
Cancer Radiother; 2007 Dec; 11(8):461-4. PubMed ID: 17689126
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
55. Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: an experience of 20 years.
Tombolini V; De Sanctis V; Donato V; Osti MF; Raffetto N; Santarelli M; Domenico V; De Nicolo M; Enrici RM
Anticancer Res; 2001; 21(2B):1413-8. PubMed ID: 11396224
[TBL] [Abstract][Full Text] [Related]
56. Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system.
Chee J; Loh KS; Tham I; Ho F; Wong LC; Tan CS; Goh BC; Lim CM
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2563-2570. PubMed ID: 28849413
[TBL] [Abstract][Full Text] [Related]
57. Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis.
Hu SX; He XH; Dong M; Jia B; Zhou SY; Yang JL; Yang S; Zhang CG; Liu P; Qin Y; Gui L
Med Oncol; 2015 Sep; 32(9):224. PubMed ID: 26219572
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
59. A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy.
Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ
Oncotarget; 2016 Jul; 7(29):46653-46661. PubMed ID: 27270307
[TBL] [Abstract][Full Text] [Related]
60. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
